These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 22538764)
1. Isolated cardiac metastasis in a patient with neuroendocrine carcinoma of pancreas discovered on ⁶⁸Ga-DOTANOC PET/CT. Khangembam BC; Naswa N; Sharma P; Bal C; Malhotra A; Kumar R J Nucl Cardiol; 2012 Oct; 19(5):1078-9. PubMed ID: 22538764 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of (68)Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors. Sharma P; Arora S; Dhull VS; Naswa N; Kumar R; Ammini AC; Bal C Abdom Imaging; 2015 Feb; 40(2):299-309. PubMed ID: 25134801 [TBL] [Abstract][Full Text] [Related]
4. ⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin. Naswa N; Sharma P; Kumar A; Soundararajan R; Kumar R; Malhotra A; Ammini AC; Bal C Clin Nucl Med; 2012 Mar; 37(3):245-51. PubMed ID: 22310250 [TBL] [Abstract][Full Text] [Related]
5. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077 [TBL] [Abstract][Full Text] [Related]
6. A rare case of neuroendocrine tumor of the middle ear detected by gallium-68-DOTANOC-PET/CT. Treglia G; Baldelli R; Cristalli G; Visca P; Barnabei A; Rufini V; Appetecchia M J Clin Endocrinol Metab; 2013 Apr; 98(4):1319-20. PubMed ID: 23401045 [No Abstract] [Full Text] [Related]
7. Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary? Naswa N; Sharma P; Gupta SK; Karunanithi S; Reddy RM; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C Clin Nucl Med; 2014 Jan; 39(1):e27-34. PubMed ID: 24217539 [TBL] [Abstract][Full Text] [Related]
8. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT. Treglia G; Salomone E; Petrone G; Giaccari A; Rindi G; Rufini V Clin Nucl Med; 2013 Jul; 38(7):e306-8. PubMed ID: 23486330 [TBL] [Abstract][Full Text] [Related]
9. Gadoxetate-enhanced versus diffusion-weighted MRI for fused Ga-68-DOTANOC PET/MRI in patients with neuroendocrine tumours of the upper abdomen. Mayerhoefer ME; Ba-Ssalamah A; Weber M; Mitterhauser M; Eidherr H; Wadsak W; Raderer M; Trattnig S; Herneth A; Karanikas G Eur Radiol; 2013 Jul; 23(7):1978-85. PubMed ID: 23471430 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ⁶⁸Ga-DOTATATE and ⁶⁸Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours. Kabasakal L; Demirci E; Ocak M; Decristoforo C; Araman A; Ozsoy Y; Uslu I; Kanmaz B Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1271-7. PubMed ID: 22526963 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified? Sharma P; Arora S; Mukherjee A; Pal S; Sahni P; Garg P; Khadgawat R; Thulkar S; Bal C; Kumar R Clin Nucl Med; 2014 Jan; 39(1):37-43. PubMed ID: 24152621 [TBL] [Abstract][Full Text] [Related]
20. 68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast. Mukherjee A; Karunanithi S; Singla S; Bal C; Kumar R Clin Nucl Med; 2014 Apr; 39(4):396-8. PubMed ID: 24566407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]